ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
What is Compensated Hypogonadism ?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 7643" data-attributes="member: 3"><p>A man with compensated hypogonadism may have high LH with normal total testosterone blood levels.</p><p></p><p>In previous studies, a significant proportion of older men have been shown to have high gonadotropins and T within the normal range. This raises the possibility of a state of compensated, or subclinical, hypogonadism that may eventually develop into overt primary hypogonadism. An analogous situation is well recognized in the pituitary-thyroid axis where high TSH, in the face of normal thyroid hormone levels, is the hallmark of subclinical hypothyroidism.</p><p></p><p>In this study, we investigated whether specific risk factors or clinical features can differentiate between secondary, primary, and the new putative form of compensated hypogonadism categorized biochemically in participants from the European Male Ageing Study (EMAS), a community-based study of middle-aged and elderly men.</p><p></p><p><a href="http://press.endocrine.org/doi/full/10.1210/jc.2009-1796" target="_blank">http://press.endocrine.org/doi/full/10.1210/jc.2009-1796</a></p><p></p><p>[ATTACH]744[/ATTACH]</p><p></p><p></p><p><strong>Characteristics of Compensated Hypogonadism in Patients with Sexual Dysfunction</strong></p><p></p><p>Corona G, Maseroli E, Rastrelli G, et al. Characteristics of Compensated Hypogonadism in Patients with Sexual Dysfunction. The Journal of Sexual Medicine. <a href="http://onlinelibrary.wiley.com/doi/10.1111/jsm.12549/abstract" target="_blank">http://onlinelibrary.wiley.com/doi/10.1111/jsm.12549/abstract</a> </p><p></p><p>Introduction </p><p></p><p>In the last few years, a view that subclinical endocrine disorders represent milder forms of the clinically overt disease has emerged. Accordingly, it has been proposed that compensated hypogonadism represents a genuine clinical subset of late-onset hypogonadism.</p><p></p><p>Aim </p><p></p><p>The aim of the present study is to investigate the associations of compensated hypogonadism with particular clinical and psychological characteristics of male subjects complaining of sexual dysfunction.</p><p></p><p>Methods </p><p></p><p>After excluding documented genetic causes of hypogonadism, an unselected consecutive series of 4,173 patients consulting our unit for sexual dysfunction was studied. Compensated hypogonadism was identified according to the European Male Ageing study criteria: total testosterone &#8805;10.5&#8201;nmol/L and luteinizing hormone >9.4&#8201;U/L.</p><p></p><p>Main Outcome Measures</p><p> </p><p>Several hormonal, biochemical, and instrumental (penile Doppler ultrasound) parameters were studied, along with results of the Structured Interview on Erectile Dysfunction (SIEDY) and ANDROTEST.</p><p></p><p>Results </p><p></p><p>One hundred seventy (4.1%) subjects had compensated hypogonadism, whereas 827 (19.8%) had overt hypogonadism. After adjustment for confounding factors, no specific sexual symptoms were associated with compensated hypogonadism. However, compensated hypogonadism individuals more often reported psychiatric symptoms, as detected by Middlesex Hospital Questionnaire score, when compared with both eugonadal and overt hypogonadal subjects (adjusted odds ratios&#8201;=&#8201;1.018 [1.005;1.031] and 1.014 [1.001;1.028], respectively; both P&#8201;<&#8201;0.005). In addition, subjects with compensated or overt hypogonadism had an increased predicted risk of cardiovascular events (as assessed by Progetto Cuore risk algorithm) when compared with eugonadal individuals. Accordingly, mortality related to major adverse cardiovascular events (MACEs), but not MACE incidence, was significantly higher in subjects with both compensated and overt hypogonadism when compared with eugonadal subjects.</p><p></p><p>Conclusions </p><p></p><p>The present data do not support the concept that compensated (subclinical) hypogonadism represents a new clinical entity. The possibility that subclinical hypogonadism could be a normal response of the hypothalamus&#8211;pituitary&#8211;testis axis to somatic illness should be considered. Further studies are urgently needed to clarify this latter point.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 7643, member: 3"] A man with compensated hypogonadism may have high LH with normal total testosterone blood levels. In previous studies, a significant proportion of older men have been shown to have high gonadotropins and T within the normal range. This raises the possibility of a state of compensated, or subclinical, hypogonadism that may eventually develop into overt primary hypogonadism. An analogous situation is well recognized in the pituitary-thyroid axis where high TSH, in the face of normal thyroid hormone levels, is the hallmark of subclinical hypothyroidism. In this study, we investigated whether specific risk factors or clinical features can differentiate between secondary, primary, and the new putative form of compensated hypogonadism categorized biochemically in participants from the European Male Ageing Study (EMAS), a community-based study of middle-aged and elderly men. [URL]http://press.endocrine.org/doi/full/10.1210/jc.2009-1796[/URL] [ATTACH=CONFIG]744[/ATTACH] [B]Characteristics of Compensated Hypogonadism in Patients with Sexual Dysfunction[/B] Corona G, Maseroli E, Rastrelli G, et al. Characteristics of Compensated Hypogonadism in Patients with Sexual Dysfunction. The Journal of Sexual Medicine. [URL]http://onlinelibrary.wiley.com/doi/10.1111/jsm.12549/abstract[/URL] Introduction In the last few years, a view that subclinical endocrine disorders represent milder forms of the clinically overt disease has emerged. Accordingly, it has been proposed that compensated hypogonadism represents a genuine clinical subset of late-onset hypogonadism. Aim The aim of the present study is to investigate the associations of compensated hypogonadism with particular clinical and psychological characteristics of male subjects complaining of sexual dysfunction. Methods After excluding documented genetic causes of hypogonadism, an unselected consecutive series of 4,173 patients consulting our unit for sexual dysfunction was studied. Compensated hypogonadism was identified according to the European Male Ageing study criteria: total testosterone ≥10.5 nmol/L and luteinizing hormone >9.4 U/L. Main Outcome Measures Several hormonal, biochemical, and instrumental (penile Doppler ultrasound) parameters were studied, along with results of the Structured Interview on Erectile Dysfunction (SIEDY) and ANDROTEST. Results One hundred seventy (4.1%) subjects had compensated hypogonadism, whereas 827 (19.8%) had overt hypogonadism. After adjustment for confounding factors, no specific sexual symptoms were associated with compensated hypogonadism. However, compensated hypogonadism individuals more often reported psychiatric symptoms, as detected by Middlesex Hospital Questionnaire score, when compared with both eugonadal and overt hypogonadal subjects (adjusted odds ratios = 1.018 [1.005;1.031] and 1.014 [1.001;1.028], respectively; both P < 0.005). In addition, subjects with compensated or overt hypogonadism had an increased predicted risk of cardiovascular events (as assessed by Progetto Cuore risk algorithm) when compared with eugonadal individuals. Accordingly, mortality related to major adverse cardiovascular events (MACEs), but not MACE incidence, was significantly higher in subjects with both compensated and overt hypogonadism when compared with eugonadal subjects. Conclusions The present data do not support the concept that compensated (subclinical) hypogonadism represents a new clinical entity. The possibility that subclinical hypogonadism could be a normal response of the hypothalamus–pituitary–testis axis to somatic illness should be considered. Further studies are urgently needed to clarify this latter point. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
What is Compensated Hypogonadism ?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top